The trial, known as Prospective Randomized Evaluation of a new Formulation: Efficacy of Rotigotine (PREFER), included a five-week titration phase followed by a 24-week maintenance phase.

• 称为新配方的前瞻性随机评价，既罗替戈汀药效(PREFER)的试验，包括一个5周的滴定期和随后24周的维持期。